HIV/HCV co-infection: Natural history

Journal of Biological Regulators and Homeostatic Agents

Volumn 17, Issue 2, 2003, Pages 144-146

  Puoti, Massimo ^a   Prestini, K ^a   Putzolu, V ^a   Zanini, B ^a   Baiguera, C ^a   Antonini, M G ^a   Pagani, P ^a   Airoldi, M ^a   Carosi, G ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Cirrhosis; HCV; Hepatitis; Hepatocellular carcinoma; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD TRANSFUSION; DISEASE COURSE; HELPER CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHOCYTE COUNT; SEXUAL BEHAVIOR; SUPERINFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0141728354     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Buffet-Janvresse C, Peigue-Lafeuille H, Benichou J, et al. HIV and HCV co-infection: Situation at six French university hospitals in the year 2000. J Med Virol 2003; 69: 7-17.
2. Thomas DL. Hepatitis C and human immunodeficiency virus infection. Hepatology 2002; 36 (Suppl.): S201-9.
3. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: June 10-12, 2002. Hepatology 2002; 36 (Suppl.): S3-20.
4. Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology 2002; 36 (Suppl.): S65-73.
5. Beld M, Penning M, Lukashov V, et al. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology 1998; 244: 504-12.
6. Cribier B, Rey D, Schmitt C, Lang JM, Kirn A, Stoll-Keller F. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS 1995; 9: 1131-6.
7. Daar ES, Lynn H, Donfield S, et al. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J Acquir Immune Defic Syndr 2001; 26: 466-72.
8. Bonacini M, Lin HJ, Hollinger FB. Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus. J Acquir Immune Defic Syndr 2001; 26: 340-4.
9. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 2001; 33: 562-9.
10. Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26: 1-5.
11. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C. The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol 1994; 87: 555-61.
12. Pol S, Fontaine H, Carnot F, et al. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients. J Hepatol 1998; 29: 12-9.
13. Frieden TR, Ozick L, McCord C, et al. Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis. Hepatology 1999; 29: 883-8.
14. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999; 30: 1054-8.
15. Puoti M, Bonacini M, Spinetti A, et al. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis 2001; 183: 134-7.
16. Bruno R, Sacchi P, Filice C, Puoti M, Filice G. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis: an emerging issue. J Acquir Immune Defic Syndr 2002; 30: 535-6.
17. Garcia-Samaniego J, Rodriguez M, Berenguer J, et al. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol 2001; 96: 179-83.
18. Laskus T, Radkowski M, Piasek A, et al. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis 2000; 181: 442-8.
19. Woitas RP, Rockstroh JK, Beier I, et al. Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients. AIDS 1999; 13: 1313-22.
20. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during anti-retroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000; 356: 1800-5.
21. Lesens O, Deschenes M, Steben M, Belanger G, Tsoukas CM. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus positive hemophilics and should be treated as an opportunistic infection. J Infect Dis 1999; 179: 1254-8.
22. Piroth L, Duong M, Quantin C, et al. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS 1998; 12: 381-8.
23. Daar ES, Lynn H, Donfield S, et al. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophilacs. J Infect Dis 2001; 183: 589-95.
24. Ockenga J, Tillmann HL, Trautwein C, Stoll M, Manns MP, Schmidt RE. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol 1997; 27: 18-24.
25. Mohsen AH, Easterbrook P, Taylor CB, Norris S. Hepatitis C and HIV-1 coinfection. Gut 2002; 51: 601-8.
26. De Luca A, Bugarini R, Lepri AC, et al. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch Intern Med 2002; 162: 2125-32.
27. Macias J, Pineda JA, Leal M, et al. Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease. Eur J Clin Microbiol Infect Dis 1998; 17: 167-70.
28. Rancinan C, Neau D, Saves M, et al. Does hepatitis C virus (HCV) coinfection modify survival in HIV patients on combinations of antiretrovirals? [Abstract 570], 8th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, USA, February 4-8, 2001.
29. Wright TL, Hollander H, Pu X, et al. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology 1994; 20: 1152-5.
30. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA 2002; 288: 199-206.
31. Dorrucci M, Pezzoti P, Phillips AN, Cozzi L, Rezza G. Co-infection of hepatitis C virus with immunodeficiency virus and progression to AIDS. J Infect Dis 1995; 172: 1503-8.
32. Staples CT, Jr., Rimland D, Dudas D. Hepatitis C in the HIV (Human Immunodeficiency Virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival. Clin Infect Dis 1999; 29: 150-4.
33. Rancinan C, Neau D, Saves M, et al. Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy? AIDS 2002; 16: 1357-62.
34. Quan CM, Krajden M, Grigoriew GA, Salit IE. Hepatitis C virus infection in patients infected with the human immunodeficiency virus. Clin Infect Dis 1993; 17: 117-9.